---
title: 5-Year Outcomes of Endovascular Treatment for Aortic Dissection From the Global
  Registry for Endovascular Aortic Treatment
date: '2024-06-02'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38825212/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240603181530&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: Results at 5-year follow-up demonstrate that the use of
  TAG/CTAG can be supported in treatment of TBAD (acute, chronic, complicated and
  uncomplicated). These data demonstrate strong device durability, beneficial patient
  outcomes, and support for treatment of thoracic aortic dissection with an endovascular
  approach. Complete 10-year follow-up in GREAT as planned will be ...'
disable_comments: true
---
CONCLUSIONS: Results at 5-year follow-up demonstrate that the use of TAG/CTAG can be supported in treatment of TBAD (acute, chronic, complicated and uncomplicated). These data demonstrate strong device durability, beneficial patient outcomes, and support for treatment of thoracic aortic dissection with an endovascular approach. Complete 10-year follow-up in GREAT as planned will be ...